Health' problem. The spread of AMR has limited the treatment options against infectious diseases. Inappropriate use of antimicrobials, is a major contributor for the development of AMR and its spread. In animal husbandry, antimicrobials are used for treating infectious diseases and in sub-therapeutic concentrations for growth promotion and disease prophylaxis. The use of antimicrobials in sub-therapeutic concentrations exerts selective pressure on bacteria and results in the emergence of bacterial strains resistant to one or more antimicrobials. The food animals raised on sub-optimal doses of antibiotics become reservoirs of resistant bacterial strains, transmitted subsequently to man and the environment. Various human, animal and environmental health agencies have decided to jointly address this problem. Establishment of integrated and harmonized AMR surveillance programmes, reduced use of antimicrobials in animal production, good governance of veterinary services, and development of new antimicrobials and their alternatives are some of the AMR management strategies in animals. Antibiotics are indispensable for human health; however, they should be totally banned in the food animals to preserve effectiveness of these drugs. In India, use of antimicrobials in food animals is limited for disease prophylaxis and growth promotion. However, absence of uniform regulations on the use of antimicrobials in animal production threatens the rationale use of these drugs in livestock.
ANTIMICROBIALS have saved millions of lives around the world. The widespread use of antimicrobials has led to the development of antimicrobial resistance (AMR) among bacteria. The problem of AMR has aggravated due to inappropriate use of antibiotics in the medical, veterinary and agricultural sectors. Globally, AMR causes about 700,000 deaths annually 1 . AMR is a public health threat both in the developing and developed world 2 . In developing countries, guidelines on the use of antimicrobials are generally absent and even if present, are not followed. In spite of several rules and regulations governing the use of antimicrobials and public awareness about the ill-effects of these drugs, the problem still exists in developed countries 3 . Continuous evolution and development of new AMR mechanisms render antimicrobials ineffective for therapeutic use. In May 2015, the World Health Assembly approved the Global Action Plan on Antimicrobial Resistance, which directs all countries to execute national AMR control plans within two years 4 . AMR is a 'One Health' problem; it affects human and animal health, and adversely impacts the environment. The Food and Agriculture Organisation (FAO)/World Organization for Animal Health (OIE)/World Health Organization (WHO) have jointly identified AMR alongside rabies and zoonotic influenza as one of the three priority public health issues under the One Health concept at animal-human-ecosystems interface 5 . Global antibiotic consumption has increased in the recent past. Increase in incomes has allowed greater access to antibiotics, and the increased appropriate and inappropriate use of these drugs. Increase in animal protein demand has shifted the animal production systems to more intensive practices with higher use of antibiotics. Both these factors have hugely added to the development and dissemination of AMR 6 . Drug-resistant bacteria can be transferred from animals to humans either directly by the food (e.g. meat, fish, eggs and dairy products) and direct contact, or, more indirectly, through the environment [6] [7] [8] [9] [10] . A number of foodborne outbreaks involving antibiotic resistant strains of Escherichia coli, Enterococcus, Aeromonas and various species of Salmonella have been linked to animal food products across the world 6 . Antimicrobial-resistant strains of Salmonella and Campylobacter are transmitted to man through foods of animal origin and result in higher mortalities than susceptible strains [11] [12] [13] . Patterns of antibiotic use in animals are reflected by trends of resistant bacteria recovered from animals, humans and the environment [6] [7] [8] . In Canada, occurrence of ceftiofur-resistant strains of Salmonella and E. coli in chickens and humans was shown to vary with the use of ceftiofur in broiler chicken farming 14 . The antibiotics used in agriculture and animal production end up in the environment, which adds to the total burden of antibiotic resistance in both animals and humans [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] . Increased movement of people, global trade of animals and food products, changing lifestyles and food habits, and increased contact between different living communities have also contributed to the worldwide spread of antimicrobial-resistant bacteria 3, 16 .
Evolution of antimicrobial resistance and mechanisms
Emergence and development of AMR is a natural, adaptive and ongoing process. It is believed that resistant bacteria were present in the environment long before the use of antibiotics started [17] [18] [19] . Antibiotic-resistant bacteria have been found in 30,000-yr-old permafrost, more than 4 million-yr-old caves, and in the guts of Amazonian tribes never exposed to drugs 20, 21 . Antimicrobial resistance imparting genetic determinants also evolved in antibiotic-producing environmental microorganisms, as an auto-protective measure 19, 22 . These resistance genotypes were later transferred to commensals and pathogenic bacteria through natural processes of genetic exchange 23 . However, presence of resistance genes is not restricted to antibiotic producers 24 . Quinolone resistance gene, qnrA was evolved in a waterborne, non-antibioticproducing bacterium, Shewanella algae 25 . Bacteria acquire AMR either through spontaneous mutations (natural AMR) or by acquiring genetic material (acquired AMR) from other microorganisms. Acquired AMR involves horizontal gene transfer between bacteria and/or acquisition of new genetic material from the environment 26 . This occurs by bacteriophage-mediated transduction (transfer of plasmids or transposons), conjugation (involving cell-to-cell contact) and/or by transformation (the direct uptake of free DNA from the environment) 27 . AMR mechanisms can be categorized into four groups 28, 29 : (1) limiting intracellular drug concentration inside the bacterium by influx and efflux; (2) chemical modifications or destruction of drugs; (3) modification of drug target sites in bacterium, and (4) development of bacterial-tolerant states, biofilm formation and swarming. Some mechanism impart cross-resistance to multiple unrelated drugs. More than one AMR mechanism can coexist in a microorganism against a single antimicrobial. AMR can be chromosomal and plasmid-mediated. Chromosomal AMR occurs due to mutations in one or more genes which render the bacterium resistant against one or more antibiotics 30 . Plasmid-mediated AMR involves the transfer of plasmids or transposons carrying various resistance genes for one or more antibiotics from donor to recipient bacterium 31 . It is further important to note that exposure to only one antibiotic can act as the selective pressure for a set of the resistance genotypes.
The selective pressure due to exposure to antimicrobials also selects resistant bacterial strains with increased survival fitness. It causes a transient and non-hereditary bacterial mechanism called persistence and selects bacterial clones with elevated mutation rates (hypermutators or mutators). A series of selection of such mutants can increase the prevalence of such strains to 100% in a selected population 32 . Therefore, exposure to a given antibiotic or antibiotic residue not only selects a bacterium for resistance to itself, but also chooses strains resistant to non-related antibiotics. AMR genes are transferred between commensals and pathogens 33 . For example, cephalosporin resistance imparting extended spectrum -lactamase (ESBL) can be transferred from E. coli to other commensals or pathogenic bacteria in the gastrointestinal tract 13, 34 .
Use of antimicrobials in animal husbandry
Antimicrobials in animal husbandry are primarily used for therapy, prophylaxis and growth promotion. They are used in bulk for prophylaxis and growth promotion in animal production 6 . Onset of disease outbreaks in animal farms is generally rapid and results in heavy mortalities. Crowded and dirty farm settings facilitate disease transmission, and antibiotics are used to check the spread of infection 35 . Antimicrobials in mass prophylaxis (metaprophylaxis) are used by mixing in feed or water to prevent infections in poultry, vertical transmission of pathogens from eggs to chicks, post-weaning infections in pigs, respiratory problems of young animals and shipping fever after transportation 2 . In dairy farms, antimicrobials are administered systematically and locally in different stages of the lactation cycle before calving as mastitis prophylaxis and its treatment during lactation 2 . Antimicrobials are used as growth promoters primarily in animal production and have no counterpart in human medicine. This dates back to the 1940s and 1950s, and accounts for the majority of antibiotic use in farm animals 6, 36 . Antibiotics act as growth promoters in food animals when fed in ultra-low doses with feed. It is estimated that between 2006 and 2050, global consumption of animal food products will double. This will result in much higher use of antimicrobial growth promoters in future 35 . In animal production, poultry and pig farming are the major consumers of antibiotics worldwide 6 . Global consumption of antimicrobials in animals is twice that of humans 37 . In the United States, 80% of the total annual antimicrobial consumption is in animals 38 . In 2013, an estimated 14,788 tonnes of antimicrobials were used in animals in USA alone. It also included 4434 tonnes of ionophores, a class of antimicrobials used only in veterinary medicine 39 . 40, 41 . In aquaculture, antibiotics are used for therapy and prophylaxis but not for growth promotion 35 . A large proportion of aquatic food production systems are in regions with inadequate regulations and restricted enforcement of law on the use of antimicrobial agents in food animals 42 . Aquaculture industry represents a significant share of the antimicrobial consumption in animal production. Extremely high rates of antimicrobial consumption have been recorded in aquaculture farming in middle and lowincome countries 43, 44 . It is believed that growth in aquaculture production systems will increase the antimicrobial consumption and contamination of the aquatic environments with antimicrobial residues in future 45 .
Antimicrobial resistance and animal husbandry sector
Antimicrobials used in animal husbandry and human medicine are mostly the same, or are from the same class. Exposure of bacteria to antibiotics or antibiotic residues in the farm environment exerts a strong selective pressure and facilitates the emergence of antibiotic-resistant bacterial strains. The farm animals may become potential reservoirs of resistant pathogens 11 . Antibiotic use in food animals influences the occurrence and distribution of resistant bacteria in humans 35, 46 . The load of resistant bacteria is higher in the guts of farmers using antibiotics as animal growth promoters than those not using them and the general population 9 . Prevalence of multidrug-resistant Staphylococcus aureus in humans has been directly associated with the time spent on animal farms 47, 48 . Similarly, occurrence of resistant bacterial strains in humans decreases with decrease in the use of antibiotics in animals 14, 35 . There are several reports on transmission of AMR strains from food animals (e.g., Salmonella spp.,
S. aureus, Campylobacter jejuni, Listeria monocytogenes,
Yersinia enterocolitica, E. coli and Enterococcus) to humans 6, 35 . Emergence of methicillin-resistant Staphylococcus aureus (MRSA) and colistin-resistant E. coli in highdensity swine production units and presence of ESBL (CT-X enzymes) producing E. coli in livestock are direct health threats to livestock handlers, farmers and veterinarians 2, 3, 35, 49 . The transmission of livestock-associated MRSA from infected animals to humans is difficult to track as MRSA infections are often asymptomatic 35 . Emergence and development of AMR in zoonotic pathogens is a serious direct public health risk because transmission is natural between animals and humans. The transfer of MRSA (clonal complex 398) has been shown to occur from infected humans to pigs and later from infected pigs to humans 50 . The selective pressure exerted by prophylactic use of antimicrobial drugs in poultry production has also resulted in the emergence of resistant E. coli and Enterococcus strains 51 . The ubiquitous nature of these organisms and their ability to adapt to different hosts and environments, further increases the transmission threats to susceptible human and animal populations. A number of studies conducted in USA and Europe have reported isolation of resistant strains of Salmonella (including non-Typhi Salmonella), S. aureus, Campylobacter, E. coli and Enterococcus from poultry, swine and cattle 6 . In these studies, AMR was reported against penicillin, tetracyclines, sulphonamides, ampicillin, quinolones, cephalosporins, macrolides and aminoglycosides 6 . The Global Antibiotic Resistance Partnership (GARP) programme has reported isolation of a variety of multidrug-resistant bacterial strains from poultry, cattle and pigs in Nepal, Uganda Tanzania and India 6 . The weaker selective pressures present in the environments other than hospitals, medical facilities and animal farms also result in the emergence of AMR 18 . Resistant bacteria, as well as antibiotic residues, have been detected in rivers, sediments, soil and other environmental sites 52 . It is reported that up to 90% of an antibiotic dose used in animals can be excreted in their urine and up to 75% in their faeces 53 . Antimicrobials or their residues are not fully biodegradable and survive water-processing or sewage treatment. They enter natural environments in different active forms 54 . They also get diluted several folds in aquatic environments and soil giving rise to new resistant bacterial strains through gene transfer 15, 52 . The effluents from animal husbandry units and slaughterhouses can discharge resistant bacteria and antibiotic residues in the receiving environments 3, 55, 56 . Application of sludge or farmyard manure carrying resistant bacteria on the fields, pastures and farmland can contaminate ground and surface waters 57, 58 . High prevalence of resistant bacteria on animal farms and in surface water directly relates to higher agricultural use of antibiotics 59 .
Biocides (e.g. alcohols, phenols, quaternary ammonium compounds and heavy metal compounds) exert selective pressure on the bacteria and also contribute to the development of AMR. Biocides in animal husbandry are used for cleaning and disinfection of farm building, preventing skin and foot infections, and to check contamination of animal products such as eggs. Biocide resistance and AMR-conferring genes are present on the same genetic elements, e.g. plasmids 14, 60 . This indirect enrichment of AMR can trigger one or more mechanisms such as up-regulation of efflux pumps or modification of target enzymes. Exposure to biocides has resulted in the emergence of E. coli isolates resistant to cotrimoxazole and amoxicillin, and Salmonella Typhimurium strain with multidrug-resistance 61, 62 . Cross-resistance to quaternary ammonium compounds and -lactam antibiotics has been reported in staphylococci 13 .
Indian scenario

Antimicrobial use in antimicrobial husbandry and antimicrobial resistance
India accounts for 3% of the global consumption of agricultural antibiotics, which is estimated to double by 2030 (ref. 41) . Studies conducted in various regions of the country have shown the presence of resistant bacteria and antimicrobial residues in food animal products (Table  1) 35,63-83 . The recent report published by Center for Disease Dynamics, Economics and Policy provides a detailed account of antibiotic use in animal production and prevalence of resistant bacterial strains in different species of livestock in India 35 . However, systematic studies estimating actual national burden of AMR are lacking. It is important to note that the use of antibiotics as growth promoters and prophylactic agents in food animals is limited in India. However, indiscriminate use of antibiotics by farmers, quacks and untrained para-veterinary staff is not monitored strictly. It is projected that India will be the fourth largest consumer of antibiotics in food animal production after China, USA and Brazil by 2030 (ref. 38) . In India, only 30% of antibiotics used in poultry is for therapy and the remaining 70% is for growth promotion 35 . The consumption of antibiotics for intensive poultry production is expected to grow by 312% between 2010 and 2030 in India 38 . Eleven of 15 antimicrobial agents considered critically important for human health by WHO and banned for agricultural use in the EU, are used in poultry feed in India 84 . Residues of antibiotics used to treat mastitis and other infectious diseases in bovines have been detected in milk samples from different parts of the country 35 . Antibiotics such as oxytetracycline, althrocin, ampicillin, sparfloxacin, enrofloxacin and ciprofloxacin are commonly used in India on fish farms, both for prophylaxis and treatment. Several studies conducted in the country have reported isolation of resistant strains of Salmonella, Vibrio cholera, Vibrio parahaemolyticus, Aeromonas, Pseudomonas, and E. coli O157:H7 from fish, crustaceans, shellfish, prawns, cuttlefish, shrimp and freshwater hatcheries 35 .
Efforts to regulate antimicrobial use in animal production in India
In India, absence of uniform regulations on antimicrobial use in animal production poses a serious challenge to the enforcement of rational antibiotic use. The exact estimates of antibiotic usage in animals are not available 85 . The National Policy for Containment of Antimicrobial Resistance released in 2011, advocates the development of strict guidelines for antibiotic use in food animals, and complete ban on non-therapeutic use of antibiotics in animals. The development of inter-sectorial collaborations for containment of AMR is emphasized in this report 35 . 'Chennai Declaration -a roadmap to tackle the challenge of antimicrobial resistance', was the first ever joint meeting of medical societies in India to address issues related to AMR 86 . It recommended the need to evaluate and regulate antibiotic usage in the veterinary practice. This document stresses the need to strictly monitor the presence of antibiotic residues and to determine the prevalence of resistant bacteria, especially zoonotic, in animals and foods of animal origin. The declaration recognized observation of proper withholding or withdrawal periods between the use of antibiotics and animal slaughter or milking as the single most important measure to circumvent antibiotic residues in milk and meat 86 . An international effort on control of AMR was made in 2011 by GARP through the 'New Delhi Call to Action on Preserving the Power of Antibiotics'. This action plan was approved by the Governments of India, Ghana, Kenya, Mozambique, South Africa and Vietnam. It emphasized the need for a multi-sectorial approach for AMR surveillance and to discourage the use of antibiotics for animal growth promotion 87 . The use antibiotics in food animals in India is broadly governed by two laws: General Statutory Rule (GSR) 28(E) and GSR588 (E). The former advocates strict observation of antibiotic withdrawal periods in foodproducing animals between the time of antibiotic administration and the production of meat/milk. The latter stipulates that antibiotics are H1 category drugs and their dispensing requires proper prescription. It is specified that withdrawal periods in meat/poultry and marine products should be 28 days and 500 degree-days respectively, for antibiotics with no defined withdrawal periods 35, 87 . Statutory Order (S.O.) 722(E) limits the use of some antibiotics in aquatic animals for export. It also provides provision to monitor antibiotic residues in eggs, honey, milk and poultry for export 41 . In 2002, S.O. 722(E) 
What needs to be done?
Antimicrobial resistance surveillance programmes
It is important to establish global and national AMR surveillance programmes for livestock. Such programmes are functional only in some EU countries, USA and Canada. According to OIE in 2012, only 27% OIE member countries officially recorded quantitative data on antimicrobial use in livestock 88 . Antibiotic resistance and its surveillance are not a priority in most low and middleincome countries. Systematic data on the use of antimicrobials are lacking for countries such as China, India and Brazil, where intensive livestock-rearing systems are increasing rapidly. WHO has recommended that countries should develop national antimicrobial surveillance programmes and assimilate AMR data from humans, foodproducing animals and retail foods of animal origin 2 . A watchful surveillance of the amount and type of antimicrobials used in humans, food products and food animals could help in the development of regulations for correct use of antibiotics 89 . In Denmark, annual antimicrobial consumption data can be traced to the individual herd level by drug classes and animal species. These kinds of data can establish a relationship between prevalence of AMR in animals and consumption of antimicrobials in farm animals 90 . It is important to keep an active supervision of environmental AMR reservoirs along with programmes directed to reduce antibiotic use in animals. Prevention of initial emergence of resistant pathogens is more important than their control after spread in human and animal populations. In India, execution of programmes such as Assistance to the States for Control of Animal Diseases (ASCAD), the National Animal Disease Reporting System (NADRS), and the National Livestock Censuses shows that the capacity for widespread data collection from the animal husbandry sector exists in the country. Successful execution of such nationwide programmes shows that it is possible to collect data on antibiotic use in animal husbandry in the country 35, 85 .
Harmonization of surveillance programmes
The major obstacles in the implementation of integrated global and national AMR surveillance programmes are lack of uniform methods (sampling, testing and reporting) and differences in protocols used in various laboratories within a country or between different countries. In order to establish effective AMR surveillance programmes, it is important to have uniformity in the bacterial species monitored, antimicrobials tested, reporting clinical breakpoints, epidemiological cut-off values, interpretation criteria (resistant, intermediately susceptible and susceptible) and control strains used. This harmonization of AMR surveillance programmes will allow better comparison of AMR data on regional, national and global levels 2 . Implementation of synchronized AMR surveillance programmes will facilitate reliable AMR data generation and formulation of region-specific intervention strategies 91 . A global or national AMR surveillance programme lacking a defined objective and universally accepted epidemiological and microbiological approaches cannot comprehensively analyse the problems of AMR. There is also a need for capacity-building and training in resource-limited countries, where the problem of AMR is often underestimated and under-reported 2 .
Emphasis on regulated use of antimicrobials in animal production
As early as the 1960s, concerns were raised about the use of antimicrobials in animal production and AMR. It was suggested that only drugs with limited or no use in human and animal therapeutics should be allowed for use as animal growth promoters 1, 6 . Inappropriate use may account for up to 50-90% of all antimicrobials consumed in human medicine; even greater proportions of antibiotics are misused in the livestock sector 1 . The antibiotic treatment is effective against bacterial infections only and should be targeted to treat such illnesses. This targeted use will prevent unnecessary antibiotic exposure to commensal bacteria and non-pathogenic bacteria which can pass resistance genes to pathogenic bacteria 85, 87 . OIE recognizes AMR as a global concern. OIE promotes the responsible and prudent use of antimicrobials in veterinary medicine to preserve their efficacy in both in animals and human. OIE has published the Terrestrial Animal Health Code and the Aquatic Animal Health Code, standards and guidelines to prevent the emergence and spread of resistant bacteria from animals 91, 92 . These documents provide detailed information on testing antimicrobial susceptibility, creating surveillance systems for antibiotic use and resistance, promoting rational antibiotic use and conducting risk analyses 91, 92 . These guidelines can be the basis for implementation of national or international AMR surveillance programmes. In 2007, the OIE International Committee approved the List of Antimicrobial Agents of Veterinary Importance (Resolution No. XXVIII) 93 . The OIE list has guidelines on restricted use of those antimicrobials in food animals that are essentially important for both animal and human health. These currently include fluoroquinolones, and third and fourth generation cephalosporins 93 . In the First Global Conference on the Prudent Use of Antimicrobials in Veterinary Medicine held at Paris in 2007, the member countries agreed to cooperate on the supervision of production, importation, marketing, distribution and use of antimicrobials 94 . Codex Alimentarius, developed by FAO and WHO, delineates maximum residue limits (MRLs) for antibiotics in foods of animal origin to warrant safety and quality in international food trade 95 .
WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (WHO-AGISAR) was set up in 2008, with an objective to minimize the public health hazards of AMR associated with the veterinary use of antimicrobials 96 . AGISAR updated the WHO list of critically important antimicrobials, meant to formulate and prioritize risk assessment and management strategies for containing AMR due to human and non-human antimicrobial use. In this list, veterinary drugs falling in the same classes of antimicrobials as those in the human medicine are now also classified separately 96, 97 . Regrettably, 9 of 14 'critically important' classes of antibiotics to human health are widely used in veterinary practice. In 2009, worldwide three most commonly used antibiotic classes in the animal sector were macrolides (US$ 600 million), penicillins (US$ 600 million), and tetracyclines (US$ 500 million). These three classes of antibiotics are categorized as critically important in human medicine 6, 98 . FAO, OIE and WHO have recommended monitoring the use of quinolones, third and fourth generation cephalosporins, and macrolides in animals for overall AMR risk assessment 6, 54 . In India, existing regulations are restricted to the detection of antibiotic residues in seafood and antibiotics used in poultry intended for export. It is important to review existing laws and develop new guidelines and standards for antibiotic use in livestock, to increase the efficacy of existing Prevention of Food Adulteration Rules Act (1955 Part XVIII) 99 .
Governance of veterinary services
OIE has stressed the need for good governance of veterinary services for better control in registration, import, distribution and for on-farm use of antimicrobials 100 . In order to prevent unnecessary chemotherapy and misuse of antibiotics in animals, the prescription and delivery of antimicrobials in animals must be performed by welltrained veterinarians. The control of ethics of veterinarians should be under the authority of a veterinary statutory body (i.e. Veterinary Council of India). Scarcity of sufficient and well-trained veterinary and para-veterinary staff is a major concern in India. The number of available veterinarians, veterinary scientists, veterinary technicians and support staff is much less compared to the proposed requirements 35 . Veterinarians, para-veterinary staff, farmers and consumers in general have failed to recognize the ill-effects antibiotic use in animal production 85 . These stakeholders need to be educated on the judicious use of antibiotics and health benefits of antibiotic-free animal products 85 .
Coordinated efforts by different stakeholders
WHO/FAO/OIE had agreed to jointly address the problem of AMR in future through expert consultations and development of guidelines 6 . The other goals of the tripartite collaboration on AMR are raising awareness, capacity-building, development of appropriate national policies and promotion of prudent and responsible use of antimicrobial drugs. Such inter-sectoral alliances will ensure better utilization of resources at the global level against AMR. The US National Antimicrobial Resistance Monitoring System (NARMS) is a collaboration of the Food and Drug Administration (FDA), the Centers for Disease Control and Prevention (CDC), and the US Department of Agriculture against AMR 5 . Successful programmes such as NARMS involving participation of different agencies and departments can be adopted by other countries for better management of AMR. WHO-AGISAR in collaboration with FAO has implemented integrated foodborne pathogen and AMR surveillance programme in food animals and aquaculture 96 . Coordination between countries is essential to develop a truly global action plan to manage AMR. These plans should be based on the 'One Health' concept covering human and animal health, agriculture and the environment 1 . International initiatives such as GARP can go a long way in developing policy alternatives to manage antibiotic effectiveness by the sharing of experiences among countries 85 .
Reducing and controlling antibiotic use in animal production sector
Emergence of resistant bacterial strains and evolution of new resistance mechanisms are directly associated with the amount and frequency of antibiotic use. Hence, phasing out the non-therapeutic use of antibiotics in animal production will decrease the burden of antibiotic-resistant infections. It has been shown that abolishing the use of antibiotics in food animals as growth promoters does not affect the production levels 101, 102 . In January 2006, addition of non-therapeutic antimicrobial drugs to animal feeds was banned in the EU 103 . Interestingly, the amount of antimicrobial use in animals fell overall by 15% between 2010 and 2012 in Europe 39 . In 2011 and 2013 in the United States, FDA issued voluntary guidelines for the producers of veterinary drugs that are added to water or feed, with the aim of eliminating the use of medically important antibiotics as growth promoters by the end of 2016 (ref. 1). In 2014, the Canadian Government implemented a voluntary strategy similar to USA. Mexico, South Korea and New Zealand have also banned the use of antibiotics as animal growth promoters 1 . Studies conducted before 1980s reported as high as 5-15% improvement in the growth rate and feed utilization efficiency of food animals on feeding sub-therapeutic antimicrobials. Interestingly, studies conducted after 2000s point towards more limited (1-5%) effects of antimicrobials as growth promoters 39, 104, 105 . The effects of removing antibiotic-based growth promoters from animal production systems are likely to differ depending on animal husbandry practices and farm conditions 1 . Prohibition on the use of antibiotics as growth promoters had a greater effect on producers with lower hygiene standards 106 . In India, a complete ban on the use antibiotics in animal production will result in 1-3% loss of annual meat production, or US$ 1110 to 2599 million. Commercial poultry farmers will have the greatest impact as poultry accounts for 50-75% of total meat production in India 35 . The effects of phasing out of antimicrobials as growth promoters can be limited by replacing less optimized animal production systems with more advanced ones 46, 107, 108 . The productivity of food animals can be increased by improving nutrition (adding probiotics and feed supplements) and by selecting food animals with superior genetic potential 33 . Intensive vaccination, improved diagnostic tools, and better hygiene and water sanitation will moderate the antibiotic demand in animal production. These measures will help in maintaining the effectiveness of current and future antibiotics for treating both humans and animals 6 .
Development of new antimicrobial agents
AMR is one of the most serious public health problems. This is of particular concern when the bacterium becomes resistant to various antimicrobial agents simultaneously. The need for new antimicrobial agents and alternatives is becoming one of the most urgent requirements in modern medicine. A systematic understanding of AMR mechanisms is critical for the development of new antimicrobial agents. After 1970s, the frequency of discovery of new antibacterial compounds dropped significantly 109 . The detection of new antimicrobial compounds from soil bacteria has become difficult because of similarity between the compounds produced 110 . The new sources which hold promise for novel antimicrobial compounds include plants, marine bio-resources, insects and venoms of various origins [111] [112] [113] [114] [115] [116] [117] . Antimicrobial peptides (AMPs) are an integral part of the natural host defence system and play a critical role in reducing the microbial load early during infection 118 . AMPs have potent antimicrobial activity, low resistance rates and a unique mode of action 116 . Due to rapid increase in antimicrobial resistance, antimicrobial peptides from synthetic and natural sources are being explored as an alternative to antimicrobial agents 118 . Lectins, the multivalent proteins present in microorganisms, animals and plants are being explored to develop novel antimicrobial agents 110 . The increasing availability of bacterial genome sequences encoding natural products has made it easier to identify the natural (including AMPs and antibiotics) products biosynthesized by microorganisms 109 . The use of synthetic biological approaches such as genome mining in combination with high-throughput sequencing platforms and integrated bioinformatic analysis can lead to the detection of novel antimicrobial compounds 111 . Three new classes of antibiotics [synercid (streptogramin combination), linezolid (oxazolidinone), and daptomycin (lipopeptide)] identified in the past were put into clinical use after improving their bioavailability and reducing the toxicity concerns 109 . Alternative therapeutic strategies like the use of inhibitors of resistance enzymes (clavulanic acid for -lactamases) and efflux pumps (reserpine, in Gram-positive bacteria), pumping antibiotics from periplasm or cytosol to the extracellular medium and use of a combination of antibiotics with different mechanisms of actions can extend the life of antibiotics 109 .
Improved sewage and farm waste disposal
Sewage treatment systems should be able to degrade antibiotic residues and destroy resistant bacteria significantly in both treated effluent and sludge 119, 120 . Ozone treatment of sewage destroys pharmaceuticals, including antibiotics and kills essentially all types of pathogenic infectious agents. Thus, ozone treatment will not only remove the selective agents (antibiotic and biocide residues), but also break transmission cycles of both susceptible and resistant microbes 18 .
Conclusion
Antimicrobials are critical in limiting the morbidity and mortality in humans and animals. The unabated use of antimicrobials in intensive animal production is decreasing the efficacy of these drugs, an indispensable component of modern medicine. In animal production, the vast majority of antibiotics are used for growth promotion and disease prevention, as a substitute for hygiene and nutrition. Use of medically 'potent' antibiotics in livestock production has raised serious concerns due to emergence and spread of AMR 1 . Antimicrobials are not ordinary products and careful considerations should be given to their use in animals. It is important to outlaw veterinary use of antibiotics critical for the preservation of human health. The farmers especially in the developing countries, should be offered incentives or subsidies to decrease antibiotic use without causing economic harm. Over the counter sale of antibiotics should banned and their end use should be ensured at the time of sale 121 . Complementary measures such as surveillance, mass education and alternative therapeutic measures will help further reduce the use of antibiotics in animals 98 . In India, too little is known about antibiotic use in food animals, and a nationwide surveillance system is required to determine antibiotic consumption and resistance patterns.
